The emergence of new therapies to limit myopia progression offers eyecare practitioners (ECPs) the opportunity to deliver better health outcomes for their patients. Despite growing calls for myopia control to become the new standard of care,(1)uptake of these new treatments by practitioners is still limited....
Lutein, zeaxanthin and meso-zeaxanthin preferentially accumulate in neural tissue, including the macula, where they form macular pigment. Macular pigment has been extensively researched in terms of ocular health and disease prevention, particularly in relation to age-related macular degeneration (AMD). A less obvious target for macular...
Scientific and industrial innovators have responded to the threat posed by myopia. We now have a rapidly increasing range of treatments available which have been shown to delay myopia onset, reduce or eliminate the progression of myopia in some children and thereby reduce the risk...
According to a recent meta-analysis of published studies, approximately 11% of COVID-19 patients have exhibited direct ocular effects (1). Typically, the complications appear to be relatively mild and short-term. ...
The emergence of the COVID-19 pandemic has had an immediate and dramatic impact on eyecare. Even now, more than a year since the emergence of this public health crisis, Covid-19 continues to overwhelm healthcare systems and resources around the globe. ...
We will now examine how a successful public health strategy for myopia might be implemented, and what policy measures might generate sufficient impact to reverse the myopia epidemic....
The management of myopia is typically practitioner-led. Currently, the standard of care is to provide single-vision spectacle or contact lenses to eliminate the blurred vision symptoms, which are characteristic of myopia....
The management of myopia is typically practitioner-led. Currently, the standard of care is to provide single-vision spectacle or contact lenses to eliminate the blurred vision symptoms, which are characteristic of myopia....
Smartphones, tablets and computers are widely used at a very early age in both home and school environments. Professor James Loughman investigates the implications of device usage for the eye health of children....
